Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(5):376-387; doi:10.1093/jnci/djh060
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (67)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ganz, P. A.
Right arrow Articles by Belin, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ganz, P. A.
Right arrow Articles by Belin, T. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

ARTICLE

Quality of Life at the End of Primary Treatment of Breast Cancer: First Results From the Moving Beyond Cancer Randomized Trial

Patricia A. Ganz, Lorna Kwan, Annette L. Stanton, Janice L. Krupnick, Julia H. Rowland, Beth E. Meyerowitz, Julienne E. Bower, Thomas R. Belin

Affiliations of authors: Schools of Medicine and Public Health (PAG, TRB), Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center (PAG, LK, ALS), Department of Psychology (ALS), Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, and Cousins Center for Psychoneuroimmunology, Neuropsychiatric Institute (ALS, JEB), University of California at Los Angeles, Los Angeles, CA; Department of Psychiatry, Georgetown University Medical Center, Washington, DC (JLK); Office of Cancer Survivorship, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (JHR); Department of Psychology, University of Southern California, Los Angeles (BEM).

Correspondence to: Patricia A. Ganz, MD, Division of Cancer Prevention and Control Research, UCLA Jonsson Comprehensive Cancer Center, Rm. A2-125 CHS, Box 956900, Los Angeles, CA 90095-6900 (e-mail: pganz{at}ucla.edu)

Background: During the last decade, survival rates for breast cancer have increased as a result of earlier detection and increased use of adjuvant therapy. Limited data exist on the psychosocial aspects of the transitional period between the end of primary treatment and survivorship. We investigated the baseline psychosocial status of women enrolled in a randomized trial testing two psychosocial interventions for women at the end of primary treatment. Methods: Participants, identified within 1 month after surgery (registration), provided demographic information and limited measures of quality of life. They were followed until they finished primary treatment (enrollment), at which time they completed a mailed baseline survey that included standardized measures of quality of life (including standardized scales of physical and emotional functioning), mood, symptoms, and sexual functioning. A total of 558 patients (mean age = 56.9 years) were enrolled in the study between July 1, 1999, and June 30, 2002. Health outcomes were examined according to treatment received: mastectomy with and without chemotherapy, and lumpectomy with and without chemotherapy. All statistical tests were two-sided. Results: Among all treatment groups, patients who had a mastectomy had the poorest physical functioning at registration (P<.001) and at enrollment (P= .05). At enrollment, mood and emotional functioning were similar among all patients, with no differences by type of treatment received. At enrollment, symptoms, including muscle stiffness, breast sensitivity, aches and pains, tendency to take naps, and difficulty concentrating, were common among patients in all groups and were statistically significantly associated with poor physical functioning and emotional well-being. Sexual functioning was worse for women who received chemotherapy than for those who did not, regardless of type of surgery (P<.001). Conclusions: At the end of primary treatment for breast cancer, women in all treatment groups report good emotional functioning but report decreased physical functioning, particularly among women who have a mastectomy or receive chemotherapy. Clinical interventions to address common symptoms associated with treatment should be considered to improve physical and emotional functioning at the end of primary treatment for breast cancer.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Health Educ BehavHome page
J. K. Vallance, K. S. Courneya, L. M. Taylor, R. C. Plotnikoff, and J. R. Mackey
Development and Evaluation of a Theory-Based Physical Activity Guidebook for Breast Cancer Survivors
Health Educ Behav, April 1, 2008; 35(2): 174 - 189.
[Abstract] [PDF]


Home page
JCOHome page
P. A. Ganz, M. A. Hussey, C. M. Moinpour, J. M. Unger, L. F. Hutchins, S. R. Dakhil, J. K. Giguere, J. W. Goodwin, S. Martino, and K. S. Albain
Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897
J. Clin. Oncol., March 10, 2008; 26(8): 1223 - 1230.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Parton and I. E. Smith
Controversies in the Management of Patients With Breast Cancer: Adjuvant Endocrine Therapy in Premenopausal Women
J. Clin. Oncol., February 10, 2008; 26(5): 745 - 752.
[Full Text] [PDF]


Home page
JCOHome page
P. A. Ganz and E. E. Hahn
Implementing a Survivorship Care Plan for Patients With Breast Cancer
J. Clin. Oncol., February 10, 2008; 26(5): 759 - 767.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. U. Lin and E. P. Winer
Advances in Adjuvant Endocrine Therapy for Postmenopausal Women
J. Clin. Oncol., February 10, 2008; 26(5): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. L. Syrjala, B. F. Kurland, J. R. Abrams, J. E. Sanders, and J. R. Heiman
Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years
Blood, February 1, 2008; 111(3): 989 - 996.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
K. L. Weihs, T. M. Enright, and S. J. Simmens
Close Relationships and Emotional Processing Predict Decreased Mortality in Women with Breast Cancer: Preliminary Evidence
Psychosom Med, January 1, 2008; 70(1): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. B. Moadel, C. Shah, J. Wylie-Rosett, M. S. Harris, S. R. Patel, C. B. Hall, and J. A. Sparano
Randomized Controlled Trial of Yoga Among a Multiethnic Sample of Breast Cancer Patients: Effects on Quality of Life
J. Clin. Oncol., October 1, 2007; 25(28): 4387 - 4395.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. K.H. Vallance, K. S. Courneya, R. C. Plotnikoff, Y. Yasui, and J. R. Mackey
Randomized Controlled Trial of the Effects of Print Materials and Step Pedometers on Physical Activity and Quality of Life in Breast Cancer Survivors
J. Clin. Oncol., June 10, 2007; 25(17): 2352 - 2359.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. A. Andrykowski, A. O. Beacham, and P. B. Jacobsen
Prospective, Longitudinal Study of Leisure-Time Exercise in Women with Early-Stage Breast Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 430 - 438.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. V. Dicpinigaitis, R. Tso, and G. Banauch
Prevalence of Depressive Symptoms Among Patients With Chronic Cough
Chest, December 1, 2006; 130(6): 1839 - 1843.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. B. Claus, S. Petruzella, D. Carter, and S. Kasl
Quality of Life for Women Diagnosed With Breast Carcinoma in Situ
J. Clin. Oncol., October 20, 2006; 24(30): 4875 - 4881.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M. Pandey, B. C. Thomas, K. Ramdas, and K. Ratheesan
Early effect of surgery on quality of life in women with operable breast cancer.
Jpn. J. Clin. Oncol., July 1, 2006; 36(7): 468 - 472.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Grunfeld, M. N. Levine, J. A. Julian, D. Coyle, B. Szechtman, D. Mirsky, S. Verma, S. Dent, C. Sawka, K. I. Pritchard, et al.
Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care
J. Clin. Oncol., February 20, 2006; 24(6): 848 - 855.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. T. Knobf
The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
Oncologist, February 1, 2006; 11(2): 96 - 110.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. S. Mandelblatt, W. F. Lawrence, J. Cullen, A. L. Stanton, J. L. Krupnick, L. Kwan, and P. A. Ganz
Patterns of Care in Early-Stage Breast Cancer Survivors in the First Year After Cessation of Active Treatment
J. Clin. Oncol., January 1, 2006; 24(1): 77 - 84.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. L. Stanton, P. A. Ganz, L. Kwan, B. E. Meyerowitz, J. E. Bower, J. L. Krupnick, J. H. Rowland, B. Leedham, and T. R. Belin
Outcomes From the Moving Beyond Cancer Psychoeducational, Randomized, Controlled Trial With Breast Cancer Patients
J. Clin. Oncol., September 1, 2005; 23(25): 6009 - 6018.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. F. Scheier, V. S. Helgeson, R. Schulz, S. Colvin, S. Berga, M. W. Bridges, J. Knapp, K. Gerszten, and W. S. Pappert
Interventions to Enhance Physical and Psychological Functioning Among Younger Women Who Are Ending Nonhormonal Adjuvant Treatment for Early-Stage Breast Cancer
J. Clin. Oncol., July 1, 2005; 23(19): 4298 - 4311.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. L. Stanton, C. A. Bernaards, and P. A. Ganz
The BCPT Symptom Scales: A Measure of Physical Symptoms for Women Diagnosed With or at Risk for Breast Cancer
J Natl Cancer Inst, March 16, 2005; 97(6): 448 - 456.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.